Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.

about

Generation and characteristics of a novel "double-hit" high grade B-cell lymphoma cell line DH-My6 with / and / gene arrangements and potential molecular targeted therapies

P2860

Q57493686-E1984D6D-DC3D-4056-B82F-9B80EA7A18D2

P2860

Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.

Item

http://www.wikidata.org/entity/Q40059586

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Differential gene expression p ...... plenic marginal zone lymphoma.

@en

type

Item

label

Differential gene expression p ...... plenic marginal zone lymphoma.

@en

prefLabel

Differential gene expression p ...... plenic marginal zone lymphoma.

@en

P1476

Differential gene expression p ...... plenic marginal zone lymphoma.

@en

P2093

Ayuko Taniguchi

http://www.w3.org/2001/XMLSchema#string

Masanori Daibata

http://www.w3.org/2001/XMLSchema#string

Mikio Kamioka

http://www.w3.org/2001/XMLSchema#string

Tomonori Higuchi

http://www.w3.org/2001/XMLSchema#string

Yumiko Hashida

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity

PLK1, A Potential Target for Cancer Therapy

The role of ephrins and Eph receptors in cancer

Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma

Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.

Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance.

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.

P2888

s41598-017-11389-5

P304

11026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-11389-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091479005

http://www.w3.org/2001/XMLSchema#string

P698

28887496

http://www.w3.org/2001/XMLSchema#string

P932

5591298

http://www.w3.org/2001/XMLSchema#string

Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.

about

P2860

P2860

Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932